{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2009-N-0374\" sorted by posted_date descending", "rows": [["FDA-2009-N-0374-0016", "FDA", "FDA-2009-N-0374", "Ellen Frank, Director Division of Public Affairs - \"Educating the Public On the Phase-Out of Epinephrine CFC Inhalers\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T23:01:22Z", null, 0, 0, "0900006480a62271"], ["FDA-2009-N-0374-0014", "FDA", "FDA-2009-N-0374", "Nancy Sander, Allergy and Asthma Network, Mothers of Asthmatics (AANMA) \"OTC Bronchodilator MDIS: Patient/Parent Perspectives\" - [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-12-02T05:00:00Z", 2009, 12, "2009-12-02T05:00:00Z", null, "2013-07-27T23:01:22Z", null, 0, 0, "0900006480a6226d"], ["FDA-2009-N-0374-0015", "FDA", "FDA-2009-N-0374", "Charlotte W. Collins, J.D., Asthma and Allergy Foundation of America (AAFA) - [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-12-02T05:00:00Z", 2009, 12, "2009-12-02T05:00:00Z", null, "2013-07-27T23:01:22Z", null, 0, 0, "0900006480a6226f"], ["FDA-2009-N-0374-0012", "FDA", "FDA-2009-N-0374", "Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop, (\"Phase Out of CFC-Propelled Epinephrine Inhalation Aerosol\"), September 25, 2009 - Transcript", "Other", "TR-Transcript", "2009-11-27T05:00:00Z", 2009, 11, "2009-11-27T05:00:00Z", null, "2009-11-27T17:24:26Z", null, 0, 0, "0900006480a5f2ca"], ["FDA-2009-N-0374-0008", "FDA", "FDA-2009-N-0374", "Steve Campbell, Esq., \"Epinephrine Use and Communication Plan\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-10-20T04:00:00Z", 2009, 10, "2009-10-20T04:00:00Z", null, "2013-08-11T03:04:29Z", null, 0, 0, "0900006480a36820"], ["FDA-2009-N-0374-0007", "FDA", "FDA-2009-N-0374", "Marcus M. Reidenberg, MD, \"Perspective on Underserved Populations: Is the Need for Prescriptions a Barrier to Care?\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-10-20T04:00:00Z", 2009, 10, "2009-10-20T04:00:00Z", null, "2013-07-27T22:56:12Z", null, 0, 0, "0900006480a36819"], ["FDA-2009-N-0374-0004", "FDA", "FDA-2009-N-0374", "Andrea Leonard-Segal, MD, \"Phase-Out of Chlorofluorocarbon (CFC)-Propelled OTC Epinephrine Metered-Dose Inhalers How to effectively spread the word?\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-10-20T04:00:00Z", 2009, 10, "2009-10-20T04:00:00Z", null, "2013-07-27T22:56:09Z", null, 0, 0, "0900006480a35054"], ["FDA-2009-N-0374-0006", "FDA", "FDA-2009-N-0374", "Leslie Hendeles, Pharm.D., \"Asthma, Epinephrine, and Therapeutic Alternatives\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-10-20T04:00:00Z", 2009, 10, "2009-10-20T04:00:00Z", null, "2013-07-27T22:56:12Z", null, 0, 0, "0900006480a36817"], ["FDA-2009-N-0374-0009", "FDA", "FDA-2009-N-0374", "Ruth Parker, MD, \"Phase Out of CFC-Propelled Epinephrine Inhalation Aerosol: Communication Challenges\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-10-20T04:00:00Z", 2009, 10, "2009-10-20T04:00:00Z", null, "2013-08-11T03:04:30Z", null, 0, 0, "0900006480a368ad"], ["FDA-2009-N-0374-0005", "FDA", "FDA-2009-N-0374", "Badrul A. Chowdhury, MD, PhD, \"Introduction and Background of CFC Propelled Epinephrine Inhalation Aerosol Phase Out\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-10-20T04:00:00Z", 2009, 10, "2009-10-20T04:00:00Z", null, "2013-08-11T03:04:29Z", null, 0, 0, "0900006480a35060"], ["FDA-2009-N-0374-0003", "FDA", "FDA-2009-N-0374", "FDA Public Workshop/Faith Dugan - Agenda", "Other", "MM-Memorandum of Meeting", "2009-10-08T04:00:00Z", 2009, 10, "2009-10-08T04:00:00Z", null, "2013-07-27T22:55:06Z", null, 0, 0, "0900006480a291ff"], ["FDA-2009-N-0374-0001", "FDA", "FDA-2009-N-0374", "Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop; Request for Comments", "Notice", "NM-Notice of Meeting", "2009-08-20T04:00:00Z", 2009, 8, "2009-08-20T04:00:00Z", "2009-11-25T04:59:59Z", "2009-08-20T15:27:33Z", "E9-19985", 0, 0, "0900006480a0e0ba"]], "truncated": false, "filtered_table_rows_count": 12, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2009-N-0374"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-N-0374", "results": [{"value": "FDA", "label": "FDA", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-N-0374", "results": [{"value": "Other", "label": "Other", "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-N-0374", "results": [{"value": 2009, "label": 2009, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&posted_year=2009", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-N-0374&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 38.746003061532974, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}